SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001047469-03-005078
Filing Date
2003-02-13
Accepted
2003-02-12 20:06:47
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 13G/A a2103016zsc13ga.htm SC 13G/A 79600
3 EX-99.1 a2103016zex-99_1.htm EX-99.1 10876
  Complete submission text file 0001047469-03-005078.txt   92721
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address
Business Address 800 E LEIGH ST SUITE 206 RICHMOND VA 23219 8088286893
INSMED INC (Subject) CIK: 0001104506 (see all company filings)

IRS No.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-59149 | Film No.: 03556477
SIC: 2834 Pharmaceutical Preparations